Kesan Physta Tongkat Ali (Nu-Prep) & Metformin: Daripada Kritikal ke Terkawal.

Dari Kritikal ke Terkawal

 

Kes Benar – Lelaki 50-an.

Dokumentasi: 22 Mac – 21 April 2026

 

Sebelum Ramadan, tubuhnya sudah memberi amaran senyap.

Gula darah kekal tinggi bahaya – 20–22 mmol/L. Jari kaki menjadi gelap, bengkak, dan sakit. Berjalan menjadi sukar. Kerosakan tisu menimbulkan risiko gangren.

 

Hari Raya ke 2.

Lawat & Merawat. 

Nu-Prep.

Nu-Prep

Dia sudah pun mengambil Metformin - ubat standard kencing manis. Namun ia tidak cukup. Tenaganya rendah. Lukanya tidak sembuh.  

Percubaan pertama – dos rendah Nu-Prep (PHYSTA® Tongkat Ali): 2 kapsul sehari. Tiada perubahan ketara.

  

Nu-Prep

 

Kemudian, dia melakukan pelarasan strategik.

Dia tingkatkan kepada 10 kapsul sehari – mengikut jadual yang teliti:

 

· 2:00 pagi (aktifkan metabolisme awal)

· 7:00 pagi (sokongan gula siang hari)

· Sebelum tidur (pemulihan malam)

 

Titik perubahan tiba ketika Ramadan.

Tiga ujian darah menunjukkan peningkatan berterusan: dari 20+ → ~9.5 → ~8 mmol/L.

Tenaganya kembali. Sakit di jari kaki mula berkurang.

Pada 11 April 2026, catatan klinik pertama merekodkan: 

"Kering, kulit cerah, bengkak mula susut"

Nu-Prep

Enam hari kemudian, 17 April 2026, catatan kedua mengesahkan kemajuan sebenar:

 "Luka cepat kering, kulit mula sambung, tidak gelap & tidak bengkak. Sakit banyak berkurangan."

 Kata doktor yang merawat: "Alhamdulillah… makin baik." 

Nu-Prep

Hari ini, 21 April 2026 – gula darah diukur 7.5 mmol/L. Doktor “sangat gembira, positif, baik.” Pesakit sungguh lega. Gangren (gangrene) semakin surut. Penyembuhan berterusan. 

Nu-Prep

Namun kami belum mengisytiharkan kemenangan akhir. Pasukan perubatan masih menunggu gula darah turun konsisten di bawah 6.5 mmol/L sebelum mengumumkan kombinasi ini sebagai protokol kejayaan.

 

Tetapi arah tujunya tidak dapat dinafikan.

Metformin + PHYSTA Tongkat Ali (Nu‑Prep) yang dioptimumkan - digunakan dengan disiplin dan pemantauan Kencing Manis - telah menarik pesakit ini dari keadaan kritikal ke arah pemulihan terkawal.

 

 

Dan kemudian datang bukti - dua lagi gambar: tarikh awal, sebelum & selepas.

 

Gambar-gambar ini bukan lakonan. Ia dokumentasi klinikal bertarikh, jujur.

Satu gambar menunjukkan jari kaki pada saat paling teruk - gelap, bengkak, terluka.

Gambar yang lain menunjukkan jari kaki yang sama beberapa hari kemudian - lebih kering, lebih cerah, bengkak kelihatan susut.

 

Sekali pandang dua gambar itu, anda akan faham:

Ini bukan mukjizat. Ini adalah ubatan + alam + disiplin.

Dan ia sedang berhasil.

 

Untuk pesakit dan keluarga:

Jangan putus asa jika Metformin sahaja tidak cukup. Gabungan semula jadi yang terstruktur dan diawasi mungkin mengubah cerita kehidupan anda ke arah yang lebih baik.

 

Untuk doktor dan klinik:

Kes dunia sebenar ini menunjukkan bahawa pengoptimuman dos PHYSTA Tongkat Ali (Nu‑Prep) boleh menyokong kawalan gula, penyembuhan luka, dan pemulihan tenaga pada pesakit diabetes jenis 2 yang kompleks.

 

Alhamdulillah. Pemulihan terus berjalan.

https://web.biotropicsmalaysia.com/zul

https://s.shopee.com.my/6AhDwsC8IB  

KEUTAMAAN.

Sila dapatkan nasihat dan rujukan daripada doktor terlebih dahulu sebelum menggunakan sebarang produk atau suplemen, terutamanya jika anda mempunyai penyakit kronik seperti kencing manis, sedang mengambil ubat preskripsi, atau dalam keadaan kritikal.

 

Kes yang dikongsikan adalah pengalaman individu. Hasil berbeza bagi setiap pesakit.

Why Some Wounds Heal Faster — And Some Don’t

 Wound Recovery.

From Inflammation to Regeneration: A Real 10-Day Case Progression

The observed wound recovery to the known bioactivity profile of Eurycoma longifolia (PHYSTA® extract).

Mechanistic Interpretation of Wound Recovery

(Linking Observed Healing → PHYSTA® Biological Actions)

1. Clinical Observation. ( from images ).

Day 0 (11/04/26): 

Nu-Prep

·       Open wound, moist surface

·       Local inflammation (swelling, discoloration)

·       Tissue disruption

 

Day 10 (21/04/26): 

Nu-Prep

·       Wound contraction + partial closure

·       Dry surface (reduced exudate)

·       New epithelial layer formation

·       Reduced edema and improved skin tone

👉 This pattern reflects transition from:

Inflammatory Phase → Proliferative Phase (healing activation)

2. Core Biological Axes Influenced by PHYSTA®

A. Hormonal Modulation (Testosterone Pathway)

PHYSTA® (standardized extract of Eurycoma longifolia) is clinically associated with:

·       Increased free testosterone

·       Reduced cortisol (stress hormone)

Why this matters for wound healing:

Testosterone enhances:

·       Fibroblast proliferation

·       Collagen synthesis

·       Keratinocyte migration (skin regeneration)

Lower cortisol reduces:

·       Chronic inflammation

·       Tissue breakdown

👉 Net effect: Accelerated transition into tissue repair phase

B. Anti-Inflammatory Modulation

Your images clearly show:

·       Reduced swelling

·       Less redness

This aligns with suppression of pro-inflammatory cytokines, such as:

·       IL-6

·       TNF-α

Mechanism: PHYSTA® bioactives (quassinoids) are linked to:

·       Downregulation of inflammatory signaling pathways

·       Reduced oxidative stress

👉 Result:

·       Faster resolution of edema

·       Reduced tissue damage

·       Lower pain signals

C. Microcirculation & Oxygen Delivery

Healing tissue requires:

·       Oxygen

·       Nutrients

·       Efficient blood flow

Observed Evidence:

·       Skin becomes brighter and more uniform

·       Indicates improved perfusion

Mechanistic Link:

Testosterone optimization contributes to:

·       Improved vasodilation

·       Enhanced nitric oxide activity

·       Better microvascular circulation

Result:

·       Increased oxygenation

·       Faster tissue regeneration

·       Healthier skin coloration

D. Cellular Regeneration (Proliferative Phase Activation)

The “dry + new skin formation” you observed indicates:

·       Re-epithelialization

·       Granulation tissue development

Biological Drivers:

·       Fibroblast activation

·       Collagen matrix deposition

·       Angiogenesis (new capillaries)

PHYSTA® indirectly supports this via:

·       Hormonal balance

·       Reduced inflammation

·       Improved circulation

3. Integrated Healing Model

Without intervention (or slow healing):

·       Prolonged inflammation

·       Poor circulation

·       Delayed closure

With PHYSTA® support (proposed model):

a.      ↓ Cortisol → inflammation control

b.      ↑ Testosterone → tissue repair activation

c.       ↑ Blood flow → nutrient + oxygen delivery

d.      → Faster wound contraction + skin regeneration

 

4. Alignment with Your Visual Evidence

Biological Mechanism	What You SEE in Image	Interpretation
Anti-inflammatory	Less swelling	Cytokine reduction
Hormonal support	Faster closure	Tissue repair activation
Circulation	Brighter skin	Improved perfusion
Regeneration	New skin layer	Active epithelialization

 

Integrated Clinical Interpretation

(Wound Healing + Glycaemic Control + PHYSTA® Mechanism)

1. Glycaemic Trend (Your Data)

a. 11 April 2026: Glucose = 8.0 mmol/L

b. April 2026: Glucose = 7.5 mmol/L

 

Direction: ↓ Reduction (≈6–7%)

While the absolute drop is modest, clinically this is meaningful in wound biology, especially in diabetic or borderline metabolic conditions.

2. Why This Matters for Wound Healing

Elevated glucose (hyperglycaemia) is known to:

·       Impair white blood cell function

·       Delay collagen synthesis

·       Reduce angiogenesis (new blood vessels)

·       Increase infection risk

Even a small reduction (8 → 7.5 mmol/L) can:

·       Improve cellular repair efficiency

·       Reduce glycation damage to tissues

·       Enhance oxygen utilization

This aligns with what we see in your images:

·       Faster drying

·       Reduced swelling

·       New skin formation

3. Blended Mechanistic Model (PHYSTA® + Glucose + Healing)

A. Hormonal Axis (Testosterone–Cortisol Balance)

From Eurycoma longifolia (PHYSTA®):

·       ↑ Testosterone → improves insulin sensitivity

·       ↓ Cortisol → reduces glucose dysregulation

 

 

Effect:

·       Better glucose control (consistent with 8 → 7.5)

* Enhanced tissue repair signaling

B. Anti-Inflammatory + Glycaemic Synergy

High glucose → drives inflammation

PHYSTA® → reduces inflammatory cytokines

Combined effect:

·       Lower systemic inflammation

·       Faster reduction in local swelling (observed)

C. Microcirculation + Glucose Utilization

Improved circulation (testosterone-mediated):

Enhances glucose delivery into cells

Improves oxygenation of damaged tissue

Outcome:

Tissue shifts from hypoxic (damaged) → regenerative state

D. Cellular Repair Efficiency

Lower glucose variability supports:

·       Fibroblast activity

·       Collagen deposition

·       Keratinocyte migration

This explains:

·       Dry wound surface

·       New epithelial layer formation

4. Integrated Evidence Table

 

Parameter	11 April	21 April	Interpretation
Glucose	8.0	7.5	Improved metabolic control
Wound moisture	Wet	Dry	Healing progression
Swelling	Present	Reduced	Lower inflammation
Tissue State	Open	Regenerated	Rसक्रिय repair phase

 

5. “The observed wound recovery coincides with improved glycaemic control and reduced inflammatory signs. The physiological effects are consistent with mechanisms associated with standardized Eurycoma longifolia extract (PHYSTA®), including hormonal balance, enhanced circulation, and anti-inflammatory modulation - factors known to support tissue regeneration.”.

https://web.biotropicsmalaysia.com/zul

https://s.shopee.com.my/6AhDwsC8IB  

"His Toe Was Turning Black. 6 Days Later, the Doctor Wrote: 'Skin Reconnecting, Pain Much Reduced

 Metformin Wasn't Enough. This Changed Everything.

Nu-Prep & diabetes.

Dated 22 March, 2026. 

In clinical context, this is almost certainly a daily blood glucose log – possibly pre- or post-meal readings. The repeated 9.5 mmol/L is significant: it is still elevated but dramatically lower than the original 20–22 mmol/L.

 

Nu-Prep & diabetes.

Dated 11 April , 2026. 

11 April 2026, Saturday

Dry, skin bright, swelling beginning to reduce

This is the earlier “before” note – already showing early healing signs, but not yet full resolution.

 

Nu-Prep & diabetes.

Dated 17 April , 2026. 

Friday, 17 April 2026

Wound dries quickly, skin beginning to reconnect, skin not dark & not swollen (reduced). Pain significantly reduced.

 

This is the later “after” note – showing clear progression.

 

Revised Case Study with Timeline & Evidence. From Critical Condition to Controlled Recovery

A Documented Case (Male, 50s) – Malaysia

 

This patient’s recovery is recorded in three pieces of evidence, all dated, all handwritten by his clinical team:

 

Date Evidence Key Findings

Before Ramadan (approx. March 2026) Verbal report + initial glucose log Glucose 20–22 mmol/L; big toe discolored, painful, tissue damage; walking difficult

11 April 2026 Clinical note #1 “Dry, skin bright, swelling beginning to reduce” – early healing

During Ramadan Glucose log (numbers) Repeated readings of ~9.5 mmol/L – stable, down from 20+

17 April 2026 Clinical note #2 “Wound dries quickly, skin reconnecting, not dark, not swollen, pain much reduced”

 

The Clinical Notes – Direct Evidence

 

Note #1 (11 April 2026 – Saturday):

(Dry, bright skin, swelling beginning to subside)

 

Note #2 (17 April 2026 – Friday):

(Wound dries quickly, skin beginning to reconnect, skin not dark & not swollen. Pain much reduced.)

 

What changed in 6 days?

 

·       From “swelling beginning to reduce” → “not swollen”

·       From “dry, bright skin” → “skin reconnecting”

·       From no mention of pain → “pain much reduced”

 

This is progressive, documented healing - not a single snapshot.

The Glucose Log – Quantitative Support

 

While the patient originally presented with 20–22 mmol/L readings, the log shows repeated values around 9.5 mmol/L – a drop of more than 50%.

 

For a patient in critical condition, stable 9.5 mmol/L during Ramadan fasting is a clinically meaningful improvement, even if not yet ideal. It represents escape from the danger zone.

 

The Treatment That Worked

 

·       Baseline: Metformin (continued throughout)

·       Adjunct: Nu‑Prep (PHYSTA® Tongkat Ali) – optimized from 2 to 10 capsules daily

·       2:00 AM: 4 capsules

·       7:00 AM: 4 capsules

·       Bedtime: 2 capsules

 

The turning point came after dose optimization. Low dose (2 capsules) did nothing. Higher, structured dosing produced measurable change.

 

Why This Matters for Domestic & International Audiences

 

For Malaysian readers:

This is Tongkat Ali – our heritage – used not as a superstition, but as a standardized, dosed adjunct alongside prescribed medication, with documented clinical follow‑up. It worked when Metformin alone was failing.

 

For international readers:

This case demonstrates a principle applicable anywhere:

 

“If a natural adjunct does not work at a low dose, do not assume it is ineffective. Dose optimization and timing may unlock its potential.”

 

It also shows that wound healing, pain reduction, and glucose stability can be documented in simple clinical notes – no expensive imaging required.

 

Current Status (as of 17 April 2026)

 

Parameter Before After (17 April)

Blood glucose 20–22 mmol/L ~9.5 mmol/L (stable)

Toe wound Dark, swollen, open Drying, reconnecting skin, not dark, not swollen

Pain Severe Much reduced

Mobility Very difficult Improved, still cautious

 

Ongoing regimen: Metformin + Nu‑Prep (10 capsules daily)

 

A Responsible Closing Note

 

This is one real‑world case, not a clinical trial.

Individual results vary. Always consult a physician before changing diabetes management.

 

But for this 50‑year‑old man - the evidence is clear:

Two clinical notes, six days apart, show progressive healing. A glucose log shows stability. And the patient’s own experience – less pain, better energy – confirms it.

 

Alhamdulillah… it is getting better.

 

Real recovery, real proof. Get Nu-Prep now before things get worse.

https://s.shopee.com.my/6AhDwsC8IB